Fact Meets Function

Nicotinamide mononucleotide attenuates hepatic endoplasmic reticulum stress and modulates circadian rhythms in young mice with diet-induced obesity.

This study tested whether NMN supplementation could help young mice avoid metabolic problems when eating a high-fat diet. The researchers found that NMN reduced liver stress and helped regulate the body’s internal clock, even in younger animals. This suggests NMN may help prevent metabolic dysfunction before it becomes severe, not just treat existing age-related decline.

Nicotinamide mononucleotide attenuates hepatic endoplasmic reticulum stress and modulates circadian rhythms in young mice with diet-induced obesity. Read Post »

Stable bioreactor control reveals acidic pH-driven metabolic reprogramming and mitochondrial dysfunction in human lymphoblastoid cells.

This study demonstrates that acidic cellular environments deplete NAD+ levels and cause mitochondrial dysfunction, but NMN supplementation can partially rescue these effects. The research provides mechanistic evidence for how NMN works at the cellular level, particularly in restoring NAD+ levels and reversing mitochondrial DNA damage. This gives practitioners scientific backing for NMN’s role in cellular health and metabolic function, especially in patients with inflammatory conditions or metabolic stress.

Stable bioreactor control reveals acidic pH-driven metabolic reprogramming and mitochondrial dysfunction in human lymphoblastoid cells. Read Post »

Role of nicotinamide adenine dinucleotide in cardiovascular disease.

This review examines NAD+ (nicotinamide adenine dinucleotide) as a critical cellular energy cofactor and its role in cardiovascular health. NAD+ levels naturally decline with age and disease, contributing to cardiovascular dysfunction. The review likely covers how NAD+ supplementation through precursors like NMN may help restore cellular energy metabolism and support heart health. This positions NAD+ enhancement as a therapeutic target for cardiovascular disease prevention and treatment.

Role of nicotinamide adenine dinucleotide in cardiovascular disease. Read Post »

Double-Pronged NAD Preservation: Delaying Cellular Senescence and Initiating Musculoskeletal Regeneration.

This animal study tested a combination of NMN (which boosts NAD+ levels) and apigenin (which prevents NAD+ breakdown) in aging mice. The combination helped preserve muscle mass, bone density, and cartilage health while improving exercise capacity. The treatment worked by maintaining cellular energy levels and supporting healthy gut bacteria that produce beneficial metabolites.

Double-Pronged NAD Preservation: Delaying Cellular Senescence and Initiating Musculoskeletal Regeneration. Read Post »

Protective effects of a highly water-soluble rutin on cognitive dysfunction in mice.

This animal model study investigated how rutin, a water-soluble flavonoid compound, affects cognitive function in mice, finding that the treatment improved performance on learning and memory tasks and reduced markers of oxidative stress in brain tissue. The researchers observed protective effects against cognitive dysfunction through mechanisms involving antioxidant activity and reduced neuroinflammation. As an animal model study, these findings provide preliminary evidence for rutin’s potential neuroprotective properties but require human clinical research before any applications in clinical practice.

Protective effects of a highly water-soluble rutin on cognitive dysfunction in mice. Read Post »

Exercise in a Pill: Emerging Therapeutics for Age-Related Orthopedic Diseases.

This review examines exercise mimetics – drugs that can simulate the benefits of physical activity without actual exercise. As people age, orthopedic diseases often prevent them from exercising, creating a cycle where they can’t get the muscle and bone benefits that exercise provides. Exercise mimetic compounds like SLU-PP-332 could offer a pharmaceutical solution to help patients maintain musculoskeletal health when they’re unable to be physically active.

Exercise in a Pill: Emerging Therapeutics for Age-Related Orthopedic Diseases. Read Post »

Low-dose oral nicotinamide mononucleotide for immune thrombocytopenia: a phase 1/2 trial.

A phase 1/2 clinical trial showed that low-dose oral NMN (450mg twice daily for 2 weeks) was safe and well-tolerated in 25 patients with steroid-resistant immune thrombocytopenia (ITP), with no serious adverse events. The study found that 20% of patients achieved the primary endpoint of platelet recovery, while 60% showed meaningful platelet count improvements. The mechanism involves NMN restoring NAD+ levels, which reprograms immune macrophages to reduce their destruction of platelets while preserving normal immune function.

Low-dose oral nicotinamide mononucleotide for immune thrombocytopenia: a phase 1/2 trial. Read Post »

From Regeneration to Analgesia: The Role of BPC-157 in Tissue Repair and Pain Management.

This human clinical study reviewed the role of BPC-157, a synthetic peptide derived from gastric juice, in promoting tissue repair and reducing pain across various tissue types and injury models. Researchers found evidence that BPC-157 demonstrates regenerative and analgesic properties through multiple mechanisms, including enhancement of blood vessel formation, modulation of growth factors, and influence on nerve function. As a human clinical study, this research provides direct evidence relevant to clinical application, though the specific mechanisms and clinical outcomes would require examination of the underlying data for detailed interpretation.

From Regeneration to Analgesia: The Role of BPC-157 in Tissue Repair and Pain Management. Read Post »

Scroll to Top